Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Benkert

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|December 20, 2024
Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated DiseaseAna Beatriz Ayroza Galvão Ribeiro Gomes, Su-Hyun Kim, Roxanne Pretzsch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 14, 2024
Complement Activation Is Associated With Disease Severity in Multiple SclerosisJohanna Oechtering, Kerstin Stein, Sabine A Schaedelin, et al.
European Journal of Epidemiology|June 26, 2026
Cohort profile: Swiss personalized health network cohort consortiumMurielle Bochud, Samuel El Bouzaïdi Tiali, Jan Armida, et al.
Neurology. Clinical Practice|July 7, 2025
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis CohortMaximilian Einsiedler, Chiara Zecca, Lisa Hofer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 26, 2022
Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional AnalysisJannis Müller, Tim Sinnecker, Maria Janina Wendebourg, et al.
Journal of Neurology|July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis CohortAlessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
JAMA Neurology|November 6, 2023
Neurofilament Light Chain Elevation and Disability Progression in Multiple SclerosisAhmed Abdelhak, Pascal Benkert, Sabine Schaedelin, et al.
Annals of Neurology|May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple SclerosisJohanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
Journal of Neurology|May 15, 2023
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysisAhmed Abdelhak, Lorenzo Barba, Michele Romoli, et al.
JAMA Neurology|February 6, 2023
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple SclerosisStephanie Meier, Eline A J Willemse, Sabine Schaedelin, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Neurology(R) Neuroimmunology & Neuroinflammation|December 20, 2024
Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated DiseaseAna Beatriz Ayroza Galvão Ribeiro Gomes, Su-Hyun Kim, Roxanne Pretzsch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 14, 2024
Complement Activation Is Associated With Disease Severity in Multiple SclerosisJohanna Oechtering, Kerstin Stein, Sabine A Schaedelin, et al.
European Journal of Epidemiology|June 26, 2026
Cohort profile: Swiss personalized health network cohort consortiumMurielle Bochud, Samuel El Bouzaïdi Tiali, Jan Armida, et al.
Neurology. Clinical Practice|July 7, 2025
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis CohortMaximilian Einsiedler, Chiara Zecca, Lisa Hofer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 26, 2022
Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional AnalysisJannis Müller, Tim Sinnecker, Maria Janina Wendebourg, et al.
Journal of Neurology|July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis CohortAlessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
JAMA Neurology|November 6, 2023
Neurofilament Light Chain Elevation and Disability Progression in Multiple SclerosisAhmed Abdelhak, Pascal Benkert, Sabine Schaedelin, et al.
Annals of Neurology|May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple SclerosisJohanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
Journal of Neurology|May 15, 2023
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysisAhmed Abdelhak, Lorenzo Barba, Michele Romoli, et al.
JAMA Neurology|February 6, 2023
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple SclerosisStephanie Meier, Eline A J Willemse, Sabine Schaedelin, et al.
Pageof 14